Harnessing Artificial Intelligence for Precision Diagnosis and Treatment of Triple Negative Breast Cancer
Clinical Breast Cancer · 2025-07 · 25 (5) · 406-421
DOI: 10.1016/j.clbc.2025.03.006 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Breast Cancer, 2025-07. Verfasst von Md Sadique Hussain und 5 weiteren Autor:innen. Beteiligte Einrichtung: Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, Uttarakhand, India. Electronic address: sadiquehussain007@gmail.c…. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Artificial Intelligence, Precision Medicine. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 134 Literaturangaben. Gefördert von: Ministry of Education, Council of Scientific and Industrial Research, India, National Research Foundation of Korea.
Abstract (Originalsprache)
Triple-Negative Breast Cancer (TNBC) is a highly aggressive subtype of breast cancer (BC) characterized by the absence of estrogen, progesterone, and HER2 receptors, resulting in limited therapeutic options. This article critically examines the role of Artificial Intelligence (AI) in enhancing the diagnosis and treatment of TNBC treatment. We begin by discussing the incidence of TNBC and the fundamentals of precision medicine, emphasizing the need for innovative diagnostic and therapeutic approaches. Current diagnostic methods, including conventional imaging techniques and histopathological assessments, exhibit limitations such as delayed diagnosis and interpretative discrepancies. This article highlights AI-driven advancements in image analysis, biomarker discovery, and the integration of multi-omics data, leading to enhanced precision and efficiency in diagnosis and treatment. In treatment, AI facilitates personalized therapeutic strategies, accelerates drug discovery, and enables real-time monitoring of patient responses. However, challenges persist, including issues related to data quality, model interpretability, and the societal impact of AI implementation. In the conclusion, we discuss the future prospects of integrating AI into clinical practice and emphasize the importance of multidisciplinary collaboration. This review aims to outline key trends and provide recommendations for utilizing AI to improve TNBC management outcomes, while highlighting the need for further research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, Uttarakhand, India. Electronic address: sadiquehussain007@gmail.com.
- Protein Engineering lab, School of Biosciences and Technology, Vellore Institute of Technology, Vellore, Tamil Nadu, India.
- Department of Bionanotechnology, Gachon University, Gyeonggi-do, South Korea.
- School of Pharmaceutical Sciences, Shri Guru Ram Rai University, Dehradun, Uttarakhand, India.
- Centre for Research Impact & Outcome-Chitkara College of Pharmacy, Chitkara University, Punjab, India; Centre of Medical and Bio-allied Health Sciences Research, Ajman University, Ajman, United Arab Emirates.
Förderung
- Ministry of Education
- Council of Scientific and Industrial Research, India
- National Research Foundation of Korea
- Gachon University
Zitieren
APA
Hussain, M. S., Ramalingam, P. S., Chellasamy, G., Yun, K., Bisht, A. S., & Gupta, G. (2025). Harnessing Artificial Intelligence for Precision Diagnosis and Treatment of Triple Negative Breast Cancer. Clinical Breast Cancer, 25(5), 406-421. https://doi.org/10.1016/j.clbc.2025.03.006
Vancouver
Hussain MS, Ramalingam PS, Chellasamy G, Yun K, Bisht AS, Gupta G. Harnessing Artificial Intelligence for Precision Diagnosis and Treatment of Triple Negative Breast Cancer. Clinical Breast Cancer. 2025;25(5):406-421. doi:10.1016/j.clbc.2025.03.006
BibTeX
@article{Hussain2025,
author = {Hussain, Md Sadique and Ramalingam, Prasanna Srinivasan and Chellasamy, Gayathri and Yun, Kyusik and Bisht, Ajay Singh and Gupta, Gaurav},
title = {Harnessing Artificial Intelligence for Precision Diagnosis and Treatment of Triple Negative Breast Cancer},
journal = {Clinical Breast Cancer},
year = {2025},
volume = {25},
number = {5},
pages = {406--421},
doi = {10.1016/j.clbc.2025.03.006}
}
EUVIMED